- Meeting abstract
- Open Access
Pulmonary resection for NSCLC in octogenarians: a single center experience
© Di Russo et al; licensee BioMed Central Ltd. 2011
- Published: 24 August 2011
- Lung Cancer
- Atrial Fibrillation
- Surgical Resection
- Respiratory Failure
- Curative Resection
Lung cancer is the second leading cancer death among octogenarians  and in particular NSCLC accounts for more than 90% of all lung cancers. Since life expectancy is improving, lung cancers are observed among octogenarians people more often. Surgical resection remains the treatment of choice for early stage lung cancer2. The authors report the outcomes of pulmonary resection for NSCLC in octogenarians.
We reviewed our center experience in elderly patients between 1999 and 2009 and reported perioperative mortality and morbidity. Thirty patients older than 80 years underwent surgical resection for NSCLC. Among these 19 lobectomies, 1 sleeve-lobectomy, 2 bilobectomies, 6 segmentectomies and 2 wedge resections were performed.
Post-operative non fatal complication occurred in 6 patients (20%): atrial fibrillation in 3 patients (10%), blood loss in 2 patients (6.6%), renal failure in 2 patients (6.6%), transitory cardiac arrhythmia in 1 patient (3%) and respiratory failure in 1 patient (3%). There was 1 post-operative death (3%).
The advances in preoperative and postoperative care and surgical technique allow a larger number of curative resections in octogenarians patients . Therefore age is not an absolute contraindication for NSCLC surgical treatment but pre-operative study is mandatory. It highlights comorbidity that can badly influence the post-operatory outcome and the survival.
- Port JL, Kent M: Surgical resection for lung cancer in Otogenarian. Chest. 2004, 126: 733-738. 10.1378/chest.126.3.733.View ArticlePubMedGoogle Scholar
- Voltolini L, Rapicetta C: Short-and long-term results of lung resection for cancer in Octogenarians. Asian Cardiovasc Thorac Ann. 2009, 17: 147-152.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.